Deregulation of HOX b13 expression in urinary bladder cancer progression

Current Medicinal Chemistry

Volumn 20, Issue 6, 2013, Pages 833-839

  Marra, L ^a,a   Cantile, M ^a   Scognamiglio, G ^a   Perdona S ^a   La Mantia, E ^a   Cerrone, M ^a   Gigantino, V ^a   Cillo, C ^b   Caraglia, M ^c   Pignata, S ^a   Facchini, G ^a   Botti, G ^a   Chieffi, S ^c   Chieffi, P ^c,d   Franco, R ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d Dipartimento di Psicologia   (Italy)

Author keywords

Bladder Tcc; Cytoplasmic Protein Expression; Hox B13; Immunohistochemistry Analysis; Muscle Invasive; Non Muscle Invasive; Nuclear Protein Expression; Real Time PCR; Transcription Factors; Tumor Progression

Indexed keywords

HOX B13 PROTEIN; HOX PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; CANCER GROWTH; CANCER PROGNOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; MUSCLE INVASIVE BLADDER TRANSITIONAL CANCER; NON MUSCLE INVASIVE BLADDER TRANSITIONAL CANCER; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TRANSITIONAL CELL CARCINOMA; TUMOR INVASION;

EID: 84877965505     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986713805076658     Document Type: Article

References (44)

1. Kömüves, L.G.; Ma, X.K.; Stelnicki, E.; Rozenfeld, S.; Oda, Y.; Largman, C. HOXB13 homeodomain protein is cytoplasmic throughout fetal skin development. Dev. Dyn., 2003, 227, 192-202. (Pubitemid 36666748)
2. Cheng, L.; Montironi, R.; Davidson, D.D.; Lopez-Beltran, A. Staging and reporting of urothelial carcinoma of the urinary bladder. Mod. Pathol., 2009, 22,70-95.
3. Holmang, S.; Hedelin, H.; Anderstrom, C.; Johansson, SL. The relationship among multiple recurrences, progression and prognosis of patients with stage Ta and Ti transitional cell cancer of the bladder followed for at least 20 years. J. Urol., 1995; 153, 1823-1827.
4. Sengupta, S.; Blute, M.L. The management of superficial transitional cell carcinoma of the bladder. Urology, 2006, 67, 48-54
5. Gehring, W.J.; Hiromi, Y. Homeotic genes and the homeobox. Annu. Rev. Genet. 1986, 20,147-173
6. Apiou, F.; Flagiello, D.; Cillo, C.; Malfoy, B.; Poupon, M.F.; Dutrillaux, B. Fine mapping of human HOX gene clusters. Cytogenetic Cell Genet., 1996, 73, 114-115. (Pubitemid 26158349)
7. Graham, A.; Papalopulu, N.; Krumlauf, R. The murine and Drosophila homeobox gene complexes have common features of organization and expression. Cell, 1989, 57, 367-78. (Pubitemid 19126271)
8. Cantile, M.; Scognamiglio, G.; Anniciello, A.; Farina, M.; Gentilcore, G.; Santonastaso, C.; Fulciniti, F.; Cillo, C.; Franco, R.; Ascierto, P.A.; Botti, G. Increased HOX C13 expression in metastatic melanoma progression. J. Transl. Med., 2012, 10,91.
9. Cillo, C.; Schiavo, G.; Cantile, M.; Bihl, M.P.; Sorrentino, P.; Carafa, V.; D' Armiento, M.; Roncalli, M.; Sansano, S.; Vecchione, R.; Tornillo, L.; Mori, L.; De, Libero, G.; Zucman-Rossi, J.; Terracciano, L. The HOX gene network in hepatocellular carcinoma. Int. J. Cancer, 2011, 129, 2577-87.
10. Podlasek, C.A.; Duboule, D.; Bushman, W. Male accessory sex organ morphogenesis is altered by loss of function of Hoxd-13. Dev. Dyn. 1997, 208, 454-65. (Pubitemid 27152838)
11. Zeltser, L.; Desplan, C.; Heintz, N. Hoxb-13: A new Hox gene in a distant region of the HOXB cluster maintains colinearity. Development. 1996, 122, 2475-84. (Pubitemid 26265606)
12. Cantile, M.; Schiavo, G.; Franco, R.; Cindolo, L.; Procino, A.; D'Armiento, M.; Facchini, G.; Terracciano, L.; Botti, G.; Cillo, C. Expression of lumbosacral HOX genes, crucial in kidney organogenesis, is systematically deregulated in clear cell kidney cancers. Anticancer Drugs, 2011, 22, 392-401.
13. Cantile, M; Franco, R.; Tschan, A.; Baumhoer, D.; Zlobec, I.; Schiavo, G.; Forte, I.; Bihl, M.; Liguori, G.; Botti, G.; Tornillo, L.; Karamitopoulou-Diamantis, E.; Terracciano, L.; Cillo, C. HOX D13 expression across 79 tumor tissue types. Int. J. Cancer, 2009, 125, 1532-41.
14. Cantile, M.; Pettinato, G.; Procino, A.; Feliciello, I.; Cindolo, L.; Cillo, C. In vivo expression of the whole HOX gene network in human breast cancer. Eur. J. Cancer., 2003, 39, 257-64. (Pubitemid 36057077)
15. Cillo, C.; Cantile, M.; Faiella, A.; Boncinelli, E. Homeobox genes in normal and malignant cells. J. Cell Physiol., 2001, 188, 161-9. (Pubitemid 32622906)
16. Miao, J., Wang, Z., Provencher, H., Muir, B., Dahiya, S., Carney, E., Leong, C.O., Sgroi, D.C., Orsulic, S. HOXB13 promotes ovarian cancer progression. Proc. Natl. Acad. Sci. USA, 2007,104, 17093-8. (Pubitemid 350210997)
17. Cazal, C.; Sobral, A.P.; De Almeida, F.C.; Das Graças Silva-Valenzuela, M.; Durazzo, M.D.; Nunes, F.D. The homeobox HOXB13 is expressed in human minor salivary gland. Oral Dis., 2006, 12, 424-7. (Pubitemid 43926823)
18. Okuda, H.; Toyota, M.; Ishida, W.; Furihata, M.; Tsuchiya, M.; Kamada, M.; Tokino, T.; Shuin, T. Epigenetic inactivation of the candidate tumor suppressor gene HOXB13 in human renal cell carcinoma. Oncogene, 2006, 25,1733-42.
19. López, R.; Garrido, E.; Pina, P.; Hidalgo, A.; Lazos, M.; Ochoa, R.; Salcedo, M. HOXB homeobox gene expression in cervical carcinoma. Int. J. Gynecol. Cancer, 2006, 16, 329-35.
20. Zhao, Y.; Yamashita, T.; Ishikawa, M. Regulation of tumor invasion by HOXB13 gene overexpressed in human endometrial cancer. Oncol. Rep., 2005, 13, 721-6.
21. Ma, X.J.; Wang, Z.; Ryan, P.D.; Isakoff, S.J.; Barmettler, A.; Fuller, A.; Muir, B.; Mohapatra, G.; Salunga, R.; Tuggle, J.T.; Tran, Y.; Tran, D.; Tassin, A.; Amon, P.; Wang, W.; Wang, W.; Enright, E.; Stecker, K., Estepa-Sabal, E.; Smith, B.; Younger, J.; Balis, U.; Michaelson, J.; Bhan, A.; Habin, K.; Baer, T.M.; Brugge, J.; Haber, D.A.; Erlander, M.G.; Sgroi, D.C. A twogene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell, 2004, 5, 607-16. (Pubitemid 38748922)
22. Jung, C.; Kim, R.S.; Zhang, H.; Lee, S.J.; Sheng, H.; Loehrer, P.J.; Gardner, T.A.; Jeng, M.H. Kao, C. HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation. Br. J. Cancer, 2005, 92, 2233-9. (Pubitemid 40966262)
23. Ghoshal, K.; Motiwala, T.; Claus, R.; Yan, P.; Kutay, H.; Datta, J.; Majumder, S.; Bai, S.; Majumder, A.; Huang, T.; Plass, C.; Jacob, S.T. HOXB13, a target of DNMT3B, is methylated at an upstream CpG island, and functions as a tumor suppressor in primary colorectal tumors. PLoS One, 2010, 5, 10338.
24. Norris, J.D.; Chang, C.Y.; Wittmann, B.M.; Kunder, R.S.; Cui, H.; Fan, D.; Joseph, J.D.; McDonnell, D.P. The homeodomain protein HOXB13 regulates the cellular response to androgens. Mol. Cell., 2009, 36, 405-16.
25. McMullin, R.P.; Mutton, L.N.; Bieberich, C.J. Hoxb13 regulatory elements mediate transgene expression during prostate organogenesis and carcinogenesis. Dev. Dyn., 2009, 238, 664-72.
26. Ewing, C.M.; Ray, A.M.; Lange, E.M.; Zuhlke, K.A.; Robbins, C.M.; Tembe, W.D.; Wiley, K.E.; Isaacs, S.D.; Johng, D.; Wang, Y.; Bizon, C.; Yan, G.; Gielzak, M.; Partin, A.W.; Shanmugam, V.; Izatt, T.; Sinari, S.; Craig, D.W.; Zheng, S.L.; Walsh, P.C.; Montie, J.E.; Xu, J.; Carpten, J.D.; Isaacs, W.B.; Cooney, K.A. Germline mutations in HOXB13 and prostatecancer risk. N. Engl. J. Med., 2012, 366, 141-9.
27. Jung, C.; Kim, R.S.; Zhang, H.J.; Lee, S.J.; Jeng, M.H. HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormoneactivated androgen receptor signaling. Cancer Res., 2004, 64,9185-9192 (Pubitemid 39665535)
28. Ewing, C.M.; Ray, A.M.; Lange, E.M.; Zuhlke, K.A.; Robbins, C.M.; Tembe, W.D.; Wiley, K.E.; Isaacs, S.D.; Johng, D.; Wang, Y.; Bizon, C.; Yan, G.; Gielzak, M.; Partin, A.W.; Shanmugam, V.; Izatt, T.; Sinari, S.; Craig, D.W.; Zheng, S.L.; Walsh, P.C.; Montie, J.E.; Xu, J.; Carpten, J.D; Isaacs, W.B.; Cooney, K.A. Germline mutations in HOXB13 and prostatecancer risk. N. Engl. J. Med., 2012, 366, 141-9.
29. Chieffi, P.; Franco, R.; Fulgione, D.; Staibano, S. PCNA in the testis of the frog, Rana esculenta: A molecular marker of the mitotic testicular epithelium proliferation. Gen. Comp. Endocrinol., 2000, 119, 11-16. (Pubitemid 30640229)
30. Chieffi, P.; Colucci D'Amato, G.L.; Staibano, S.; Franco, R.; Tramontano, D. Estradiol-induced mitogen-Activated protein kinase (extracellular signalregulated kinase 1 and 2) activity in the frog (Rana esculenta) testis. J. Endocrinol. 2000, 167, 77-84.
31. Franco, R.; Esposito, F.; Fedele, M.; Liguori, G.; Pierantoni, G.; Botti, G.; Tramontano, D.; Fusco, A.; Chieffi, P. Detection of high mobility group proteins A1 and A2 represents a valid diagnostic marker in post-puberal testicular germ cell tumors. J. Pathol. 2008, 214, 58-64.
32. Franco, R.; Boscia, F.; Gigantino, V.; Marra, L.; Esposito, F.; Ferrara, D.; Pariante, P.; Botti G.; Caraglia, M.; Minucci, S.; Chieffi, P. GPR30 is overexpressed in post-puberal testicular germ cell tumors. Cancer Biol. Ther. 2011, 11:609-13.
33. Esposito, F., Boscia, F.; Franco, R.; Tornincasa, M.; Fusco, A.;Kitazawa, S.; Looijenga, L.H.; Chieffi, P. Down-regulation of oestrogen receptor-Associates with transcriptional co-regulator PATZ1 delocalization in human testicular seminomas. J. Pathol. 2011, 224:110-20.
34. Esposito, F.; Boscia, F.; Gigantino, V.; Tornincasa, M.; Fusco, A.; Franco, R.; Chieffi, P. The high mobility group A1-oestrogen receptor nuclear interaction is impaired in human testicular seminomas. J. Cell. Physiol. 2012, 227, 3749-3755.
35. Kelly, Z.L.; Michael, A.; Butler-Manuel, S.; Pandha, H.S.; Morgan, R.G. HOX genes in ovarian cancer. J. Ovarian Res. 2011, 4,16.
36. Gray, S.; Pandha, H.S.; Michael, A.; Middleton, G.; Morgan, R. HOX genes in pancreatic development and cancer. JOP, 2011, 12, 216-9.
37. Shah, N.; Sukumar, S. The Hox genes and their roles in oncogenesis. Nat. Rev. Cancer, 2010, 10, 361-71.
38. Cantile, M.; Franco, R.; Schiavo, G.; Procino, A.; Cindolo, L.; Botti, G.; Cillo, C. The HOX genes network in uro-genital cancers: mechanisms and potential therapeutic implications. Curr. Med. Chem., 2011, 18, 4872-84.
39. Simon, R.; Struckmann, K.; Schraml, P.; Wagner, U.; Forster, T.; Moch, H.; Fijan, A.; Bruderer, J.; Wilber, K.; Mihatsch, M.J.; Gasser, T.; Sauter, G. Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer. Oncogene, 2002; 21, 2476-83. (Pubitemid 34438100)
40. Cantile, M.; Cindolo, L.; Napodano, G.; Altieri, V.; Cillo, C. Hyperexpression of locus C genes in the HOX network is strongly associated in vivo with human bladder transitional cell carcinomas. Oncogene, 2003; 22, 6462-8. (Pubitemid 37281694)
41. Maeda, K.; Hamada, J.; Takahashi, Y.; Tada, M.; Yamamoto, Y.; Sugihara, T.; Moriuchi, T. Altered expressions of HOX genes in human cutaneous malignant melanoma. Int. J. Cancer, 2005, 114, 436-41 (Pubitemid 40279966)
42. Kömüves, L.G.; Ma, X.K.; Stelnicki, E.; Rozenfeld, S.; Oda, Y.: Largman, C. HOXB13 homeodomain protein is cytoplasmic throughout fetal skin development. Dev. Dyn., 2003, 227, 192-202. (Pubitemid 36666748)
43. Zachos I.; Tzortzis V.; Konstantinopoulos P.A.; Karatzas A.; Gravas S.; Melekos M.; Papavassiliou A.G. Molecular pathogenesis of non muscleinvasive bladder cancer: implications for novel targeted therapies. Curr Mol Med. 2011, 11:623-32.
44. Holmäng S.; Hedelin H.; Anderström C.; Johansson S.L. Long-Term followup of all patients with muscle invasive (stages T2, T3 and T4) bladder carcinoma in a geographical region. J Urol. 1997, 158:389-92. (Pubitemid 27327673)